Document Detail


A call to action for more aggressive treatment of hypertension.
MedLine Citation:
PMID:  10340837     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
During the past three decades, tremendous progress has been made in the USA and many other nations in detecting and controlling hypertension. Health education efforts increased public knowledge of the benefits of treating hypertension, and rates of blood pressure control improved. Despite improvements in the past, however, more recent information has shown some disturbing trends; we are not as healthy a nation as we could be. Hypertension control rates are no longer improving, and are likely to fall short of the US Healthy People 2000 goal of blood pressure control in 50% of all hypertensive patients. Overwhelming data from clinical trials underscore the need to control hypertension, especially in the elderly, for whom hypertension control rates are lower than they are for the total US population. Data from the Framingham Study indicate that the incidence of heart failure increases with age and is greater in hypertensive patients than in normotensive patients. Hypertension precedes heart failure in 90% of all cases, and the prevalence of heart failure, greater today than it was a decade ago, is now the largest component of the Medicare budget (Medicare is the US health insurance and standards for medical participation program for those aged 65 years and older). Hypertension is also associated with an increase in the incidence of end-stage renal disease, and stroke and coronary heart disease may be increasing again. Such alarming trends are a call to action for the public, patients, and health professionals. Strong evidence supports the need for better blood pressure control, with an emphasis on the elderly and other difficult-to-treat populations.
Authors:
C Lenfant; E J Roccella
Related Documents :
11772297 - An update on the status of endothelin receptor antagonists for hypertension.
11355047 - 24-hour ambulatory blood pressure monitoring in primary care.
341667 - A pathophysiologic basis for the diagnosis and treatment of the renal hypertensions.
15025837 - Aii antagonists in hypertension, heart failure, and diabetic nephropathy: focus on losa...
23632067 - Plantar pressure distribution in a hyperpronated foot before and after intervention wit...
3777057 - The effect of carbohydrate overfeeding on blood pressure in the pregnant, spontaneously...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Journal of hypertension. Supplement : official journal of the International Society of Hypertension     Volume:  17     ISSN:  0952-1178     ISO Abbreviation:  J Hypertens Suppl     Publication Date:  1999 Feb 
Date Detail:
Created Date:  1999-07-15     Completed Date:  1999-07-15     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  8501422     Medline TA:  J Hypertens Suppl     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  S3-7     Citation Subset:  IM    
Affiliation:
National Heart, Lung, and Blood Institute, Department of Health and Human Services, Public Health Service, National Institutes of Health, Bethesda, Maryland 20892, USA. lenfant@gwgate.nhlbi.nih.gov
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Antihypertensive Agents / therapeutic use*
Blood Pressure / drug effects
Heart Failure / epidemiology,  etiology,  prevention & control
Humans
Hypertension / complications,  drug therapy*,  epidemiology
Incidence
Kidney Failure, Chronic / epidemiology,  etiology,  prevention & control
Patient Education as Topic
Prevalence
Treatment Outcome
United States / epidemiology
Chemical
Reg. No./Substance:
0/Antihypertensive Agents

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The antihemorrhagic factor of the Mexican ground squirrel, (Spermophilus mexicanus).
Next Document:  The Hypertension Optimal Treatment study and the importance of lowering blood pressure.